tiprankstipranks
Aesthetic Medical International Holdings Group (PAIYY)
OTHER OTC:PAIYY

Aesthetic Medical International Holdings Group (PAIYY) AI Stock Analysis

41 Followers

Top Page

PAIYY

Aesthetic Medical International Holdings Group

(OTC:PAIYY)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 5.2)
Rating:45Neutral
Price Target:
$0.09
▼(-70.69% Downside)
Action:ReiteratedDate:02/04/26
The score is driven primarily by mixed financial performance: improving revenue, sharply reduced operating losses, and stronger cash flow are offset by ongoing net losses and a highly leveraged balance sheet. Technicals add downside risk with price below key moving averages and negative MACD, while valuation cannot be meaningfully assessed due to missing P/E and dividend yield.
Positive Factors
Revenue Growth
A 10.7% revenue increase indicates durable demand expansion and better market traction for the company's services. Over a 2-6 month horizon, sustained top-line growth can support fixed-cost absorption, improve operating leverage, and create a clearer path to sustained profitability if cost discipline continues.
Negative Factors
Highly Leveraged Balance Sheet
An equity ratio of 6.3% signals heavy reliance on debt financing and a thin equity cushion. This structural leverage increases sensitivity to interest costs, restricts strategic options, and heightens refinancing and solvency risk over the medium term, especially if cash generation underperforms expectations.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
A 10.7% revenue increase indicates durable demand expansion and better market traction for the company's services. Over a 2-6 month horizon, sustained top-line growth can support fixed-cost absorption, improve operating leverage, and create a clearer path to sustained profitability if cost discipline continues.
Read all positive factors

Aesthetic Medical International Holdings Group (PAIYY) vs. SPDR S&P 500 ETF (SPY)

Aesthetic Medical International Holdings Group Business Overview & Revenue Model

Company Description
Aesthetic Medical International Holdings Group (PAIYY) is a leading provider of aesthetic medical services and products in China. The company operates a network of outpatient clinics that offer a wide range of non-surgical aesthetic procedures, in...
How the Company Makes Money
The company generates revenue primarily through its aesthetic medical services offered at its clinics. This includes fees from various non-invasive procedures and treatments that clients seek for cosmetic enhancements. Additionally, PAIYY earns in...

Aesthetic Medical International Holdings Group Financial Statement Overview

Summary
Mixed fundamentals: revenue grew 10.7% and EBIT losses narrowed significantly (from -48.81M to -4.04M), with improving free cash flow and solid operating cash flow. However, profitability remains negative and the balance sheet is highly leveraged with a very low equity ratio (6.3%), increasing financial risk.
Income Statement
45
Neutral
Balance Sheet
40
Negative
Cash Flow
50
Neutral
BreakdownDec 2024Dec 2023Mar 2023Dec 2021Mar 2021
Income Statement
Total Revenue755.67M682.59M670.09M645.59M901.57M
Gross Profit337.79M322.05M355.59M269.50M544.78M
EBITDA73.33M25.31M-11.05M-554.95M-123.90M
Net Income-19.95M-37.43M-76.25M-586.62M-235.48M
Balance Sheet
Total Assets486.22M560.66M546.37M576.94M1.04B
Cash, Cash Equivalents and Short-Term Investments42.84M62.34M12.16M39.29M44.38M
Total Debt179.30M244.55M393.10M405.91M460.79M
Total Liabilities476.88M527.03M672.25M763.36M612.35M
Stockholders Equity30.46M48.89M-113.66M-156.67M390.90M
Cash Flow
Free Cash Flow48.88M18.83M-76.80M17.65M-46.01M
Operating Cash Flow79.67M74.29M-75.13M51.09M-843.00K
Investing Cash Flow-30.32M-52.25M3.11M-11.53M-127.37M
Financing Cash Flow-68.55M29.06M45.55M-45.23M17.70M

Aesthetic Medical International Holdings Group Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.29
Price Trends
50DMA
0.06
Positive
100DMA
0.10
Negative
200DMA
0.14
Negative
Market Momentum
MACD
0.01
Negative
RSI
65.75
Neutral
STOCH
80.49
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PAIYY, the sentiment is Neutral. The current price of 0.29 is above the 20-day moving average (MA) of 0.06, above the 50-day MA of 0.06, and above the 200-day MA of 0.14, indicating a neutral trend. The MACD of 0.01 indicates Negative momentum. The RSI at 65.75 is Neutral, neither overbought nor oversold. The STOCH value of 80.49 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for PAIYY.

Aesthetic Medical International Holdings Group Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
49
Neutral
$7.91M-0.34-253.43%94.52%
45
Neutral
$5.29M-76.57%
41
Neutral
$3.80M-1.60-164.27%4.59%-920.22%
40
Underperform
$7.17M-1.29-220.42%-41.03%35.71%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PAIYY
Aesthetic Medical International Holdings Group
0.11
-0.01
-10.00%
NCNA
Nucana
1.90
-143.90
-98.70%
CELZ
Creative Medical Technology Holdings
2.21
0.41
22.78%
HSCS
Heart Test Laboratories, Inc.
2.25
-1.25
-35.71%
TNMG
TNL Mediagene
1.49
-7.92
-84.20%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 04, 2026